BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9336747)

  • 1. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.
    Laufer MR; Townsend NL; Parsons KE; Brody KA; Diller LR; Emans SJ; Guinan EC
    J Reprod Med; 1997 Sep; 42(9):537-41. PubMed ID: 9336747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation.
    Poorvu PD; Barton SE; Duncan CN; London WB; Laufer MR; Lehmann LE; Marcus KJ
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):265-8. PubMed ID: 26506031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.
    Chiusolo P; Salutari P; Sica S; Scirpa P; Laurenti L; Piccirillo N; Leone G
    Bone Marrow Transplant; 1998 Apr; 21(8):821-3. PubMed ID: 9603407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
    Arias RD; Jain JK; Brucker C; Ross D; Ray A
    Contraception; 2006 Sep; 74(3):234-8. PubMed ID: 16904417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report.
    Pereyra Pacheco B; Méndez Ribas JM; Milone G; Fernández I; Kvicala R; Mila T; Di Noto A; Contreras Ortiz O; Pavlovsky S
    Gynecol Oncol; 2001 Jun; 81(3):391-7. PubMed ID: 11371127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.
    Kowalik A; Barmat L; Damario M; Liu HC; Davis O; Rosenwaks Z
    J Reprod Med; 1998 May; 43(5):413-7. PubMed ID: 9610463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction.
    Silva AL; Abreu LG; Rosa-e-Silva AC; Ferriani RA; Silva-de-Sá MF
    Steroids; 2008 Dec; 73(14):1475-84. PubMed ID: 18789958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy.
    Khurana KK; Singh SB; Tatum AH; Schulz V; Badawy SZ
    J Reprod Med; 1999 Jun; 44(6):487-92. PubMed ID: 10394541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results.
    Mericq V; Lammoglia JJ; Unanue N; Villaroel C; Hernández MI; Avila A; Iñiguez G; Klein KO
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):686-90. PubMed ID: 19302581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?
    Cox MC; Scripture CD; Figg WD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):605-11. PubMed ID: 16111462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
    Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
    Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH
    BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of menstrual suppression and uterine bleeding: a survey of current practices in the Pediatric Blood and Marrow Transplant Consortium.
    Adegite EA; Goyal RK; Murray PJ; Marshal M; Sucato GS
    Pediatr Blood Cancer; 2012 Sep; 59(3):553-7. PubMed ID: 22331813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation.
    Ghalie R; Porter C; Radwanska E; Fitzsimmons W; Richman C; Kaizer H
    Am J Hematol; 1993 Apr; 42(4):350-3. PubMed ID: 8493984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do heavier women benefit from a higher dose of leuprolide acetate for suppression of serum estradiol?
    Muneyyirci-Delale O; Weisberg GW
    Int J Fertil Womens Med; 2000; 45(6):368-71. PubMed ID: 11140546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.